Results 251 to 260 of about 35,539 (289)

Closer look at autism and the measles-mumps-rubella vaccine

Journal of the American Pharmacists Association, 2010
To educate pharmacists regarding the hypothesis that the measles-mumps-rubella (MMR) vaccine is linked to the development of autism.Articles published from 1998 to 2009 were identified through electronic searches of Medline.Articles were included if they evaluated or reviewed a possible link between the MMR vaccine and autism or discussed MMR ...
Leslie A. Briars, Emily Hensley, Emily Hensley   +2 more
openaire   +3 more sources

Is an Improved Measles-Mumps-Rubella Vaccine Necessary or Feasible?

Critical Reviews in Immunology, 2003
The measles-mumps-rubella (MMR) vaccine has been very effective in the elimination of disease and has high biosafety. However, it has been associated with several adverse effects and has recently caused controversy with regard to its possible association with inflammatory bowel disease and autism.
S Louise Cosby, Gregory J. Atkins
openaire   +3 more sources

Neurologic Disorders After Measles-Mumps-Rubella Vaccination

Pediatrics, 2002
Objective. The possibility of adverse neurologic events has fueled much concern about the safety of measles-mumps-rubella (MMR) vaccinations. The available evidence concerning several of the postulated complications is controversial. The aim of this study was to assess whether an association prevails between MMR vaccination and encephalitis, aseptic ...
J. Pekka Nuorti, Heikki Peltola, Annamari Mäkelä   +2 more
openaire   +3 more sources

Response to measles-mumps-rubella vaccine in children on dialysis

Pediatric Nephrology, 1992
Ten children receiving maintenance dialysis were immunized with the standard dose of measles-mumps-rubella vaccine between 15 and 33 months of age. Immune responses to vaccination were determined using commercially available enzyme-linked immunosorbent assays for measles, mumps, and rubella viruses.
H J Baluarte, Bruce A. Kaiser, Seth Schulman, Martin S. Polinsky, Adamadia Deforest   +4 more
openaire   +3 more sources

Two Doses of Measles Mumps Rubella (MMR) Vaccine

Pediatrics International, 1989
A schedule of two doses of measles mumps rubella vaccine (MMR) at an interval of six weeks was tried in children aged between 12 and 48 months. One hundred percent seroconversion was attained in the measles HI (hemagglutinin inhibition) test, rubella HI test, and mumps ELISA test in both groups of children who received NIH (National Institute of Health,
Mikio Kimura, Harumi Kuno-Sakai, Kazuyo Ozaki   +2 more
openaire   +3 more sources

Measles-mumps-rubella vaccine and the development of autism

Seminars in Pediatric Infectious Diseases, 2003
The measles-mumps-rubella (MMR) vaccine has been postulated to cause a form of autism characterized by regression and bowel symptoms, and onset occurring shortly after vaccination. It is also claimed that, as a result, there has been a dramatic increase in autism prevalence.
openaire   +2 more sources

Evaluation of a trivalent measles, mumps, rubella vaccine in children

The Journal of Pediatrics, 1975
Vaccine. The vaccine was a combination of Schwarz strain live, attenuated measles virus, 2 Jeryl Lynn strain five, attenuated mumps virus? and Cendehill strain live, and attenuated rubella virus? Three different production lots were used in this study.
H. Graubarth, M.T. Kenny, R.W. Lipp, Gilbert M. Schiff, J.E. Jackson, J.L. Bloom, R.L. Osborn   +6 more
openaire   +3 more sources

Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.

Journal of the American Medical Association (JAMA), 1971
Four lots of combined trivalent Moraten measles, Jeryl Lynn mumps, and HPV-77 duck rubella vaccine were administered to a total of 715 children, 7 months to 7 years of age, who were initially without antibody against any of the three viruses. Overall, 96%
Joseph Stokes, R. Weibel, V. Villarejos, G. JorgeA.Arguedas, E. Buynak, Maurice R. Hilleman   +5 more
semanticscholar   +1 more source

A combination vaccine against measles, mumps, rubella and varicella

Drugs of Today, 2008
A new combination vaccine against measles, mumps, rubella and varicella (MMRV) from GlaxoSmithKline Biologicals has recently been approved in Europe. It combines the components from two well-established, live, attenuated vaccines against measles, mumps and rubella.
Markus Knuf, Jörg Faber, Immanuel Barth, P. Habermehl   +3 more
openaire   +3 more sources

Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.

Pediatrics, 1988
The safety and efficacy of simultaneous administration of measles-mumps-rubella (MMR), diphtheria-tetanus-pertussis (DTP), and trivalent oral poliovirus (OPV) vaccines in a test group of 405 children were compared with the safety and efficacy of ...
A. Deforest, S. Long, H. Lischner, J. Girone, Janet L. Clark, Ranganathan Srinivasan, T. Maguire, Susan A. Diamond, R. P. Schiller, E. Rothstein, Neil Schlackman, T. Hipp, R. Souder, R. Bernier   +13 more
semanticscholar   +1 more source